Amalgamated Bank Has $40.80 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Amalgamated Bank lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 78,171 shares of the medical equipment provider’s stock after purchasing an additional 1,592 shares during the quarter. Amalgamated Bank’s holdings in Intuitive Surgical were worth $40,802,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Bennett Selby Investments LP grew its position in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares during the period. LVW Advisors LLC grew its position in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after buying an additional 19 shares during the period. Wesbanco Bank Inc. grew its position in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares during the period. Journey Strategic Wealth LLC grew its position in shares of Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after buying an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC grew its position in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after buying an additional 19 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.1 %

Shares of ISRG opened at $591.01 on Tuesday. The company has a market cap of $210.51 billion, a price-to-earnings ratio of 92.20, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company’s fifty day simple moving average is $566.43 and its 200 day simple moving average is $526.49.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 188 shares of the company’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $101,332.00. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,720,023. The trade was a 2.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,240 shares of company stock worth $3,529,040. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Evercore ISI lifted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Jefferies Financial Group lifted their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, Bernstein Bank lifted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.